Abstract
Inositol is a key precursor for synthesis of phosphatidylinositol in a major second messenger signalling system. It is biologically active in syndromes such as respiratory distress syndrome but has been thought to be excluded from CNS by the blood-strain barrier. Oral inositol treatment of 8 patients is shown to significantly increase CSF inositol by almost 70%, suggesting possible CNS therapeutic applications of this compound and possible CNS side-effects of systemic therapy.
Original language | English |
---|---|
Pages (from-to) | 168-170 |
Number of pages | 3 |
Journal | Brain Research |
Volume | 627 |
Issue number | 1 |
DOIs | |
State | Published - 5 Nov 1993 |
Keywords
- Blood-brain barrier
- Cerebrospinal fluid
- Inositol
- Second messenger
ASJC Scopus subject areas
- General Neuroscience
- Molecular Biology
- Clinical Neurology
- Developmental Biology